AMENDMENT TO FINANCING COMMITMENT LETTERFinancing Commitment Letter • March 27th, 2020 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment to Financing Commitment Letter (this “Amendment”) is made by and between Qualigen, Inc., a Delaware corporation (the “Company”) and Alpha Capital Anstalt (“Alpha”) and is dated March 9, 2020. This Amendment amends the letter agreement dated January 15, 2020 (the “Financing Commitment Letter”) by and between the Company and Alpha. Capitalized terms used in this Amendment and not otherwise defined shall have the meanings ascribed to those terms in the Financing Commitment Letter or, if no such meaning is ascribed there, then to the meaning ascribed to the term in the Merger Agreement.
